European Neuropsychopharmacology, 19(S9), S681S682
The results are not directly comparable to systemic Thymosin Beta-4 or TB-500 administration Key distinction: TB-500 is a synthetic fragment designed to mimic aspects of Thymosin Beta-4
Untreated vascular risk factors, like high blood pressure, can accelerate the progression of dementia, especially Alzheimer's disease
Image items used in this work were created in BioRender: Ethics declarations Competing interests The authors declare no competing interests
It is the appropriate course of action for both therapeutic truth-telling and fiscal stability
5-amino-1MQ is a small, selective, membrane-permeable molecule that works to prevent the production of excess NNMT, targeting the source problem